mibefradil has been researched along with Atrial Fibrillation in 3 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (33.33) | 18.2507 |
| 2000's | 1 (33.33) | 29.6817 |
| 2010's | 1 (33.33) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Duker, G; Fjellstrom, O; Giordanetto, F; Iwasaki, YK; Kato, T; Nattel, S; Sundqvist, M; Wallin, A; Wang, QD | 1 |
| Bénardeau, A; Fareh, S; Nattel, S; Thibault, B | 1 |
| Bénardeau, A; Fareh, S; Nattel, S | 1 |
3 other study(ies) available for mibefradil and Atrial Fibrillation
| Article | Year |
|---|---|
Inefficacy of a highly selective T-type calcium channel blocker in preventing atrial fibrillation related remodeling.
Topics: Action Potentials; Animals; Atrial Fibrillation; Atrial Remodeling; Calcium Channel Blockers; Calcium Channels, T-Type; Cardiac Pacing, Artificial; Disease Models, Animal; Dogs; Electrophysiologic Techniques, Cardiac; Heart Atria; Mibefradil; Refractory Period, Electrophysiological; Time Factors | 2014 |
The T-type Ca(2+) channel blocker mibefradil prevents the development of a substrate for atrial fibrillation by tachycardia-induced atrial remodeling in dogs.
Topics: Animals; Atrial Fibrillation; Atrial Function; Calcium Channel Blockers; Calcium Channels, T-Type; Dogs; Heart Atria; Mibefradil; Refractory Period, Electrophysiological; Tachycardia | 1999 |
Differential efficacy of L- and T-type calcium channel blockers in preventing tachycardia-induced atrial remodeling in dogs.
Topics: Analysis of Variance; Animals; Atrial Fibrillation; Calcium Channel Blockers; Calcium Channels, L-Type; Calcium Channels, T-Type; Diltiazem; Dogs; Electric Countershock; Electrocardiography; Heart Atria; Mibefradil; Single-Blind Method; Statistics, Nonparametric; Tachycardia | 2001 |